Roche Holding AG's Fiscal Year is From January To December - All Figures are in CHF, Billions.
The item "Selling-General-and-Administrative" stands at 13.87 Billion Swiss Francs for the trailing twelve months (TTM) period ending 06/30/2025, the highest value since 12/31/2022.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 117.47 percent compared to the value the year prior.
The 1 year change in percent is 117.47.
The 3 year change in percent is 15.07.
The 5 year change in percent is -15.12.
The 10 year change in percent is -17.58.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Selling General and Administrative | 905,699,262,464.00 |
![]() | Johnson & Johnson - Selling General and Administrative | 486,508,953,600.00 |
![]() | AbbVie Inc - Selling General and Administrative | 399,570,305,024.00 |
![]() | AstraZeneca PLC - Selling General and Administrative | 280,205,508,085.11 |
![]() | Novartis AG - Selling General and Administrative | 255,096,620,580.91 |